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Abstract 
src-related cytoplasmic PTKs are physically and functionally associated with cell surface receptors and are involved in signal transduction. In this 
paper we report the identification of src-related proteins p5Fn, ~~60’” and ~62~” in human microvascular endothelial cells cultured from normal 
human skin and their physical association with the thrombospondin receptor CD36. Such an association represents a potential signalling pathway 
by which thrombospondin may regulate angiogenesis. 
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1. Introduction 
The microvascular endothelium is normally quiescent 
but is nevertheless able to undergo rapid differentiation 
and proliferation during angiogenesis and wound heal- 
ing. The signalling pathways responsible for endothelial 
cell activation are not clear. However studies in other cell 
types have indicated that cell phenotype is influenced by 
its extra-cellular matrix (ECM) [l] and that cell surface 
ECM protein receptors are involved in relaying signals 
between the ECM and the cell [2]. CD36 is an integral 
membrane protein that is thought to have a role in signal 
transduction [3]. It is an 88 kDa antigen originally iden- 
tified on platelets (and named GPIV) and subsequently 
shown to be expressed on a variety of cells including 
microvascular endothelium 143. However, expression of 
CD36 on endothelium is not universal, even within the 
same vascular bed [5]. CD36 is a receptor for throm- 
bospondin [6] and its expression on the microvascular 
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Abbreviations: ECM, extracellular matrix; PTK, protein tyrosine ki- 
nase, HUVEC, human umbilical vein endothelial cells; HDMEC, 
human dermal microvascular endothelial cells; PHS, pooled human 
serum; Iscove’s DMEM, Iscove’s modification of Dulbecco’s modified 
Eagle’s medium; DTT, dithiotreitol; PMSF, phenyl methyl sulphonyl 
fluoride; LB, lysis buffer; BSA, bovine serum albumin; NRS, normal 
rabbit serum; SDS, sodium dodecyl sulphate; RIPA, radioimmunopre- 
cipitation assay; TBS, T&buffered saline; SDS-PAGE, SDS-poly- 
acrylamide gel electrophoresis; BCIP, bromo-4-chloro-3-indoyl phos- 
phate; NBT, nitroblue tetrazolium; 
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endothelial cell surface may well be influenced by the 
presence of thrombospondin, as has been suggested by 
in vitro experiments using embryonic fibroblasts [7]. 
Antibody cross-linking of the CD36 receptor activates 
both platelets [8] and monocytes [9] and, in platelets, 
immunoprecipitation with anti-CD36 antibodies co-pre- 
cipitates the src-related protein tyrosine kinases (PTKs) 
(EC 2.7.1.112) p56/p581y”, p59fyn and p6ryyes [lo]. Phos- 
phorylation of proteins on tyrosine residues by PTKs is 
an important mechanism regulating cellular responses to 
exogenous stimuli and there is increasing evidence that 
the src-related cytoplasmic PTKs are physically and 
functionally associated both with receptor PTKs and 
with cell surface membrane receptors that do not possess 
PTK activity [l 11. For example, in T- cells, ~56”~ isasso- 
ciated with the CD4 and CD8ol proteins [12] and p59’y” 
is associated with the T-cell antigen receptor complex 
1131. 
src-related proteins have been identified in large vessel 
endothelium. The fj~n gene has been cloned from a 
cDNA library prepared from human umbilical vein en- 
dothelial cells (HUVEC) [14] and c-src mRNA and pro- 
tein have been identified in bovine aortic endothelial cells 
[15]. However, as already indicated, blood vessel endo- 
thelium is not homogeneous. 
We have therefore sought evidence for the presence of 
src-related PTKs in human dermal microvascular endo- 
thelial cells (HDMEC). By analogy with platelets it may 
be proposed that CD36 is linked to cytoplasmic src- 
related PTKs in microvascular endothelium. Such an 
association would be a potentially important mechanism 
for regulating endothelial cell responses to changes in its 
ECM at sites of injury. We have therefore sought evi- 
dence for a physical association between CD36 and 
members of thz src-reiated PTK family in HDMEC. 
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2. Materials and methods 
2.1. Human dermal microvascular endothelial cell cultures 
HDMEC were isolated from neonatal foreskin obtained after routine 
circumcision and established in culture as previously described [16]. The 
HDMEC were cultured on fibronectin-coated culture wells in Iscove’s 
modification of Dulbecco’s modified Eagles culture medium (Iscove’s 
DMEM; Gibco, UK) containing 1-methyl-3_isobutylxanthine, dibu- 
tyryl cyclic-AMP and 30% (v/v) pooled human serum (PHS). 
Confluent monolayers of cells between passages 2 and 4 were used 
for these experiments. 
2.2. Immunoprecipitation 
HDMEC were washed twice with serum-free culture medium con- 
taining 100 pM sodium orthovanadate (Na,VO,). Lysates were pre- 
oared bv adding 0.5 ml lvsis buffer (LB: 50 mM Tris HCl, pH 7.5, 150 
AM NaCI, O.S< (v/v) N&idet P40, ‘1 ;M EDTA, 1 mM diihiothreitol 
(DTT), 100 PM Na,VO,, 1 mM phenyl methyl sulphonyl fluoride 
(PMSF), 20 PM leupeptin) to each 25 cm’ culture flask. Lysates were 
then transferred to microfuge tubes, vortexed, incubated on ice for 30 
min and centrifuged (10,000 xg, 10 min) to remove nuclei and cell 
debris. The lysates were divided into two aliquots and stored at -20°C. 
Protein concentrations were estimated using the Bradford assay with 
bovine serum albumin (BSA) prepared in 1110 dilution of LB as the 
standard [17]. 
Immunoprecipitations were carried out using the method described 
by Courtneidge [18,19]. Fixed Staphylococcus aureus cells (Pansorbin, 
Calbiochem, UK) was first pre-incubated with normal rabbit serum 
(NRS). 500 ~1 of 10% (w/v) Pansorbin was incubated with 50 ~1 NRS 
on ice’for 3d min, washed three times with immunoprecipitation buffer 
(RIPA: 50 mM Tris-HCI. DH 7.5. 150 mM NaCI. 1% (v/v) Triton 
k-100,’ 1% (v/v) sodium ‘deoxycholate, 0. I % (w/vj sodiim ‘dodecyl 
sulphate (SDS), 1 mM EDTA, 1 mM DTT, 100 PM Na,VO,, 1 mM 
PMSF, 20 PM leupeptin) and resuspended in LB at a concentration of 
5% (w/v). Cell lysates were then pre-adsorbed with NRS-treated Pan- 
sorbin. Lysate containing 100 pg of protein was added to 1110 volume 
of NRS-treated Pansorbin and incubated on ice for 30 min. The Pan- 
sorbin was pelleted by centrifugation (10,000 x g, 5 min) and the super- 
natant transferred to a clean microfuge tube. 0.5 pg antibody protein 
was added to the pre-adsorbed lysate, mixed and incubated at 4°C 
overnight (18 h). The samples were then centrifuged (10,000 x g, 5 min) 
and the supernatant transferred to a clean microfuge tube. Fresh Pan- 
sorbin was prepared by washing three times in RIPA buffer and 5 ~1 
of washed Pansorbin per ~1 antiserum were added to each tube. After 
45 min incubation on ice, the Pansorbin-bound immune complexes 
were pelleted by centrifugation (10,000 x g, 10 min) and washed three 
times with LB buffer and once with Tris buffered saline (TBS; 25 mM 
Tris-HCl, pH 7.5, 150 mM NaCl, I mM EDTA, 1 mM DTT). The 
immune complexes were then eluted in 25 ,fd single-strength SDS-poly- 
acrylamide gel electrophoresis (SDS-PAGE) sample buffer (1% (w/v) 
SDS, 4% (w/v) sucrose, 4 mM EDTA, 90 mM Tris-HCI, pH 6.8). 
2.3. Electrophoresis and immunoblotting 
Cell lysates diluted in an equal volume of double-strength SDS- 
PAGE sample buffer and immune complexes suspended in single- 
strength SDS-PAGE sample buffer were heated at 100°C for 3 min and 
the insoluble material precipitated by centrifugation (10,000 x g, 5 
min). Proteins were size-fractionated by SDS-PAGE using 3% (w/v) 
uolyacrylamide in the stacking gel and 10% (w/v) polyacrylamide in the 
ie&lviig gel and then electroblotted onto 0.45 p& nitrocellulose mem- 
branes (Schleicher and Schuell, Dassel, Germany) 1201. Residual pro- 
tein binding sites were blocked by soaking the bldts for 2 h in i‘risl 
Tween buffer (150 mM Tris-HCI, pH 7.5, 150 mM NaCl, 0.05% (v/v) 
Tween 20) containing 3% (w/v) BSA. After washing three times for 5 
min in Tris/Tween buffer the blots were incubated overnight at 4°C 
with different antibodies diluted in TrislTween buffer containing 3% 
(w/v) BSA. The next morning the blots were washed three times for 5 
min with Tris/Tween buffer and then incubated with alkaline phosphat- 
ase conjugated goat anti-mouse or goat anti-rabbit IgG (Southern Bio- 
technologies, Birmingham, Alabama) diluted in TrislTween buffer with 
3% (w/v) BSA for 2-3 h at room temperature. The blots were then 
washed twice for 5 min with Tris/Tween buffer and developed with 
bromo-l-chloro-3-indoyl phosphate/Nitro blue tetrazolium (330 &ml 
BCIP, 150 &ml NBT prepared in 100 mM Tris-HCI, pH 9.5,lOO mM 
NaCI, 5 mM MgCI,) for IO-30 min at room temperature. The colour 
development was quenched by washing the blots under running water. 
2.4. Antibodies and reagents 
The antibodies used for the immune precipitations and Western blot 
analysis included an affinity purified polyclonal rabbit antiserum that ___-. 
recognizes ahomologous region of the C-terminal of p60’.“, ~59’” and 
~62”” (Santa Cruz Biotechnology, Santa Cruz, California), affinity 
purified polyclonal and monoclonal antibodies directed against the _.._ 
blatelet receptor GP88 (CD36, GPIV)(generous gifts from Dr Michael 
Berndt, Baker Research Institute, Melbourne, Australia) and polyclo- 
nai antiserum (whole serum) directed against ~59’“” (a generous gift 
from Professor Mike Waterfield, Ludwig Institute, UCL Branch). 
3. Results 
3.1. src-related PTKs in human dermal microvascular en- 
dothelial cells 
In Western blots of protein extracted from HDMEC, 
the c-srclfynlyes antiserum detected two strong bands 
with molecular weights of approximately 60 kDa (Fig. 
1A) and the fyn antiserum detected a broad band with 
a molecular weight of approximately 60 kDa (Fig. 1B). 
These results demonstrate that microvascular endothe- 
lial cells express thefyn PTK and possibly the c-src and 
c-yes PTKs. 
3.2. CD36 in human dermal microvascular endothelial 
cells 
We next investigated the expression of immunoreac- 
tive CD36 in HDMEC. Anti-CD36 antibodies detected 
a broad band with an approximate molecular weight of 
between 80 kDa and 90 kDa in Western blots of protein 
Fig. 1. Western blots of whole cell extracts of unstimulated HDMEC 
were incubated with anti-c-srclfynlyes, antiserum (A), anti-fyn antise- 
rum (B), anti-CD36 antiserum (C) followed by alkaline phosphatase 
conjugated second layer antiserum, or with alkaline phosphatase con- 
jugated second layer antiserum alone (D). Molecular weight markers 
are indicated on the right-hand side of the blot. 
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Fig. 2. Western blots of immune complexes precipitated with anti- 
CD36 antiserum were incubated with anti-c-&j&yes antiserum (A) 
or anti&n antiserum (B) followed by alkaline phosphatase conjugated 
second antiserum layer, or with alkaline phosphatase conjugated sec- 
ond antiserum layer alone (C). Molecular weight markers are indicated 
on the right-hand side of the blot. 
extracted from HDMEC (Fig. 1C). Two bands with mo- 
lecular weights of approximately 80 kDa and 88 kDa 
were visible within the broad band. 
3.3. Association of CD36 with src-related proteins 
We next investigated whether src-related PTKs were 
physically associated with CD36 in HDMEC. 
Protein extracts of HDMEC were immunoprecipi- 
tated with the polyclonal anti-CD36 antiserum and the 
resultant Western blots were incubated with the anti-c- 
srclfynlyes antiserum or the anti-fyn antiserum (Fig. 2). 
Both the anti-c-srclfynlyes antiserum (Fig. 2A) and the 
anti-fyn antiserum (Fig. 2B) detected a band with a mo- 
lecular weight of approximately 60 kDa in CD36 im- 
munoprecipitates. The broad intensely staining band of 
approximately 50-55 kDa results from binding of the 
second antibody to the immunoglobulin heavy chain in 
the Pansorbin immunoprecipitates (Fig. 2C). 
Finally, protein extracts of HDMEC were im- 
munoprecipitated with the anti-c-srclfynlyes antiserum 
or the anti-fyn antiserum and the resultant immunoblots 
were incubated with the anti-CD36 antiserum (Fig. 3). 
This antiserum detected two bands with molecular 
weights of approximately 80 kDa and 88 kDa (Fig. 
3A,C). A band with a molecular weight of approximately 
70 kDa was also detected. This band was only a minor 
component in the c-srclfynlyes immunoprecipitates but 
in the fyn immunoprecipitates, the bands with molecular 
weights of approximately 70 kDa and 80 kDa were 
stained with equal intensity whilst the 88 kDa band was 
hardly visible. As before, the second antibody also 
bound to the immunoglobulin heavy chain in the im- 
munoprecipitates (Fig. 3B). 
4. Discussion 
These data indicate that src-related PTKs are present 
in human microvascular endothelium and that the mem- 
brane receptor CD36 is physically associated with p5pfYn 
and possibly with pp60““” and ~62’-~“. 
The antibody raised against human platelet CD36 
(GP88, GPIV) detected a broad band with molecular 
weight ranging from approximately 80-90 kDa in West- 
em blots of whole cell extracts of HDMEC. Within the 
broad band it was possible to detect two bands with 
molecular weights of approximately 80 kDa and 88 kDa. 
These two bands were clearly defined on Western blots 
of immune complexes precipitated with the anti-c-srcl 
fynlyes antiserum and incubated with the anti-CD36 an- 
tiserum and an additional feint band with a molecular 
weight of approximately 70 kDa was also detected. In 
Western blots of anti-fyn immune complexes incubated 
with anti CD36 antiserum, the 70 kDa and 80 kDa bands 
were stained with equal intensity. CD36 is heavily glyco- 
sylated with both N- and O-linked carbohydrate moieties 
and the different bands present on Western blots may 
represent proteins with different degrees of glycosyla- 
tion. 
It is not possible to establish the nature of the interac- 
tion between CD36 and the src-related PTK from these 
data. The different staining intensities of the three CD36 
bands in Western blots of anti-c-srclfynlyes immune 
complexes and anti-fyn immune complexes incubated 
c 
498 
466 
Fig. 3. Western blots of immune complexes precipitated with anti-c- 
srcl’ynlyes antiserum (A,B) or antizfyn antiserum (C) were incubated 
with the anti-CD36 antiserum followed by alkaline phosphatase con- 
jugated second antiserum layer (A,C), or with alkaline phosphatase 
conjugated second antiserum layer alone (B). Molecular weight mark- 
ers are indicated on the right-hand side of the blot. 
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with anti-CD36 antiserum may be due steric hinderance 
since the anti-c-srclfynlyes antiserum is directed against 
the COOH-terminal common to all three proteins whilst 
the anti-&n antiserum is directed against the unique 
NH,-terminal. Alternatively, the p5!#“” binding site on 
CD36 may be different to those of pp60”~“” and ~62~‘~. 
The function of ~59”~ and src-related PTK in 
HDMEC is not known. Phosphotyrosine has been lo- 
calised at focal contacts and intercellular junctions in a 
variety of cell types [21] and in early passage NIH 3T3 
cells transfected with normal c-src, fyn or c-fgr cDNAs 
there was increased tyrosine phosphorylation of the focal 
adhesion kinase ~129~ [22]. The increased tyrosine 
phosphorylation of p12pk was most evident in cells 
transfected with normalfyn cDNA suggesting that src- 
related PTK and p59fv” in particular are localized in focal 
adhesion plaques at least in 3T3 cells. Overexpression of 
normal ~59”” in NIH 3T3 cells contributes to the forma- 
tion of non-contact inhibited clusters (transformed foci) 
[23] which is preceded by disruption of the focal adhesion 
plaques. These data indicate that ~59~” may play a role 
in the modulation of cell adhesion. 
Our data suggest he possibility that ~59’~~ is involved 
in mediating changes in microvascular endothelial cell 
adhesion in response to binding of thrombospondin to 
CD36 on the cell surface. This represents a potentially 
important signal transduction pathway in angiogenesis 
since loss of contact between the endothelial cell and its 
ECM is an initial event in the generation of new blood 
vessels. 
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